Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Voyager Therapeutics (VYGR)
NASDAQ:VYGR
Voyager Therapeutics (VYGR) Ownership - Who Owns Voyager Therapeutics?
605 Followers
Voyager Therapeutics (VYGR) Ownership Overview
44.22% Insiders
14.25% Mutual Funds
13.42% Other Institutional Investors
28.10% Public Companies and
Individual Investors
The ownership structure of Voyager Therapeutics (VYGR) stock is a mix of institutional, retail and individual investors. Approximately 27.68% of the company’s stock is owned by Institutional Investors, 44.22% is owned by Insiders and 28.10% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 03, 2024 | Robin Swartz Coo | xxxxxxxxxxxxx | $13407 |
| Apr 03, 2024 | Alfred Sandrock President & Ceo,director | xxxxxxxxxxxxx | $119454 |
| Feb 22, 2024 | Robin Swartz Coo | xxxxxxxxxxxxx | $29547 |
| Feb 22, 2024 | Alfred Sandrock President & Ceo,director | xxxxxxxxxxxxx | $97226 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $93463 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $297966 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $2793000 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $21338520 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,589,359 | Institution | 4.76% | 23,200,657 | |
| 2,396,322 | Institution | 4.41% | 21,471,045 | |
| 2,292,000 | Institution | 4.21% | 20,536,320 | |
| 2,045,404 | Institution | 3.76% | 18,326,820 | |
| 964,577 | Institution | 1.77% | 8,642,610 | |
| 917,916 | Institution | 1.69% | 8,224,527 | |
| 738,846 | Institution | 1.36% | 6,620,060 | |
| 539,291 | Institution | 0.99% | 4,832,047 | |
| 534,308 | Institution | 0.98% | 4,787,400 | |
| 507,407 | Institution | 0.93% | 4,546,367 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,396,322 | Institution | 4.41% | 21,471,045 | |
| 738,846 | Institution | 1.36% | 6,620,060 | |
| 539,291 | Institution | 0.99% | 4,832,047 | |
| 534,308 | Institution | 0.98% | 4,787,400 | |
| 507,407 | Institution | 0.93% | 4,546,367 | |
| 457,063 | Institution | 0.84% | 4,095,284 | |
| 414,562 | Institution | 0.76% | 3,714,476 | |
| 332,867 | Institution | 0.61% | 2,982,488 | |
| 233,481 | Institution | 0.43% | 2,091,990 | |
| 176,492 | Institution | 0.32% | 1,581,368 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,627,895 | Institution | 2.99% | 13,674,318 | |
| 1,120,897 | Institution | 2.06% | 10,020,819 | |
| 902,512 | Institution | 1.66% | 8,068,457 | |
| 823,450 | Institution | 1.51% | 7,361,643 | |
| 774,470 | Institution | 1.42% | 6,505,548 | |
| 423,287 | Institution | 0.78% | 3,784,186 | |
| 324,824 | Institution | 0.60% | 2,848,706 | |
| 148,603 | Institution | 0.27% | 1,248,265 | |
| 121,654 | Institution | 0.22% | 1,066,906 | |
| 99,201 | Institution | 0.18% | 869,993 |
FAQ
Who Owns Voyager Therapeutics (VYGR)?
According to the latest TipRanks data, approximately 13.42% of the company's stock is held by institutional investors, 44.22% is held by insiders, and 28.10% is held by retail investors.
What percentage of Voyager Therapeutics (VYGR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 13.42% of Voyager Therapeutics (VYGR) stock is held by institutional investors.
What percentage of Voyager Therapeutics (VYGR) stock is held by retail investors?
According to the latest TipRanks data, approximately 28.10% of Voyager Therapeutics (VYGR) stock is held by retail investors.
Who owns the most shares of Voyager Therapeutics (VYGR)?
Vanguard owns the most shares of Voyager Therapeutics (VYGR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.